![]() IO Biotech IO Biotech is a clinical-stage biotech company developing immune-modulating cancer therapies. | ![]() Cullgen Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders. | |||
Founding Date | Founding Date 2018 | Founding Date 2014 | Founding Date 2018 | Founding Date 2015 |
Type | Type Private | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations Poitiers, FR HQ Chasseneuil Du Poitou, FR | Locations New York, US HQ København, DK Usk, GB Rockville, US | Locations San Diego, US HQ Shanghai, CN Tokyo, JP | Locations Gaithersburg, US HQ |
Employees | Employees 833% increase | Employees 19 | Employees 4 | Employees 78 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 85.3 m | Valuation ($) N/A | Valuation ($) 4.7 b |
Financial | ||||
Net income | Net income N/A | Net income ($95.5m) (FY, 2024) | Net income N/A | Net income ($228.9m) (FY, 2025) |
Funding | ||||
Latest funding round | Latest funding round $ 720.5k (over 6 years ago) | Latest funding round N/A | Latest funding round $ 16m (about 7 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 720.5k | Total funding raised $ 165.9m | Total funding raised $ 31m | Total funding raised $ 200m |

IO Biotech is a clinical-stage biotech company developing immune-modulating cancer therapies.
View company
Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders.
View company
Arcellx is a clinical-stage biotechnology company developing adaptive immune cell therapies.
View company